| 000 | 01748 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513040434.0 | ||
| 264 | 0 | _c19930923 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1993.11.9.1795 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSavarese, D M | |
| 245 | 0 | 0 |
_aPhase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cSep 1993 |
||
| 300 |
_a1795-803 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnthraquinones _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Marrow Diseases _xchemically induced |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 700 | 1 | _aDenicoff, A M | |
| 700 | 1 | _aBerg, S L | |
| 700 | 1 | _aHillig, M | |
| 700 | 1 | _aBaker, S P | |
| 700 | 1 | _aO'Shaughnessy, J A | |
| 700 | 1 | _aChow, C | |
| 700 | 1 | _aOtterson, G A | |
| 700 | 1 | _aBalis, F M | |
| 700 | 1 | _aPoplack, D G | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 11 _gno. 9 _gp. 1795-803 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1993.11.9.1795 _zAvailable from publisher's website |
| 999 |
_c7688516 _d7688516 |
||